Topics
Glioblastoma | Treatment | CXCL12 inhibitors
Home > Publications > Topics > Glioblastoma > Treatment > CXCL12 inhibitors
Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R,
Corvino D, Zeyen T, Schaub C, Müller W, Sperk E, Schmeel LC,
Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten
M, Glas M, Seidel C, Herrlinger U, Hölzel M.
L-RNA
aptamer-based CXCL12 inhibition combined with radiotherapy in
newly-diagnosed glioblastoma: dose escalation of the phase I/II
GLORIA trial.
Nat
Commun. 2024 May 28;15(1):4210. doi:
10.1038/s41467-024-48416-9. PMID:
38806504.
Interventional study. ˍ